Simulmedia Announces Partnership with M3 MI’s

Simulmedia Partners with M3 MI for Enhanced Targeting in Healthcare Advertising

New York, NY – [Sept 17, 2024] – Simulmedia announces a strategic partnership with M3 MI, improving its TV+ Advertising Platform. This collaboration enables pharma marketers to target patient audiences effectively across streaming TV, utilizing M3 MI’s robust national panel data.

M3 MI's approach is based on survey responses from the MARS Consumer Health Study, offering a privacy-forward solution that aligns with evolving healthcare legislation. This partnership helps pharma marketers reach relevant patient populations while ensuring compliance with future-proof data practices for CTV advertising.

Challenges in Pharmaceutical Advertising

Pharma marketers face difficulties in reaching strategic patient audiences efficiently due to tightening privacy regulations. Traditional audience data often lacks the accuracy needed for precise targeting, leading to wasted ad spend. Additionally, caregivers, who are crucial in healthcare decisions, are often overlooked.

Partnership Benefits

Simulmedia’s collaboration with M3 MI strengthens its TV+ Advertising Platform, leveraging first-party, consent-based survey data for precise targeting. This method ensures comprehensive audience coverage while safeguarding privacy by removing survey seed data and mitigating re-identification risks. It's a secure and effective way for pharma marketers to reach both patient and caregiver audiences, ensuring compliance with privacy regulations.

Quotes from Leadership

Pravin Chandiramani, SVP Business Development of Simulmedia, stated: "Pharma marketers face growing challenges in reaching their target audiences with precision while ensuring compliance with increasingly stringent privacy regulations. By partnering with M3 MI, we’ve integrated their first-party, consent-based data into our TV+ Advertising Platform, enabling pharma brands to target patient and caregiver audiences with unparalleled accuracy and security."

Dave Emery, Managing Director at M3 MI, added: "Our partnership with Simulmedia allows us to address the critical need for privacy-compliant engagement with patient and caregiver audiences. Together, we can deliver highly precise, privacy-safe campaigns across streaming TV."

Execution of Campaigns

To utilize M3 MI's targeting capabilities, clients work with their Simulmedia Client Success Manager to define their target audience. After audience definition, a comprehensive proposal is provided, detailing campaign execution on streaming TV, including specific targeting parameters. Simulmedia then integrates M3 MI data into the platform and activates the campaign, with clients receiving real-time performance metrics.

About Simulmedia

Simulmedia is a technology company founded in 2008, based in New York. It provides Performance TV® products powered by its AI-driven TV+® analytic and activation platform. Simulmedia delivers targeted video ad campaigns across streaming and linear TV channels for over 100 brands. Independent studies suggest that Simulmedia campaigns achieve 30-100% higher ROI compared to conventionally planned campaigns.

About M3 MI

M3 MI is a leading provider of audience research and advertising intelligence for the healthcare industry, offering 100% opt-in, privacy-safe consumer health audiences for activation. M3 MI helps pharma brands understand their customers better and how to communicate with them effectively.